Comphya is a Swiss medical device company and EPFL spin-off located at the EPFL Innovation Park in Lausanne, dedicated to developing clinical solutions for urological disorders.
Subscribe to see Comphya’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Comphya is a medical technology company headquartered in Switzerland. It has raised at least $10.5M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round, Series A, raised $7.5M in July 2025. Xcout tracks 6 named people at Comphya, including Pim van Wesel (Chief Executive Officer).
At least $10.5M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $7.5M | — | |
| Seed | Undisclosed | — | |
| — | $3M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Comphya's closest competitors — see the full list of competitors and alternatives →
Pulsify Medical is a cardiovascular medical technology company based in Leuven, Belgium, that develops novel ultrasound solutions and devices.
Argá Medtech SA is a privately held medical device company based in Switzerland that develops advanced energy delivery systems and cardiac medical technologies.
Bright Uro, Inc. is a medical technology enterprise based in Irvine, California, that manufactures advanced diagnostic devices for bladder health, including its Glean UDS urology testing system. The company develops innovative clinical solutions designed to improve diagnostic capabilities for both clinicians and patients.
Synergia Medical is a medical technology company developing NAO, a next-generation neuromodulation platform designed to advance neural stimulation therapies. The company operates from Belgium.
Pelvital USA, Inc. is a women's health medical device company that develops products to restore pelvic health. The company offers Flyte, an FDA-cleared treatment designed to promote cellular healing in pelvic floor muscles and treat stress urinary incontinence.
CASCINATION AG is a Swiss medical device company that develops robotic and image-guided solutions for clinicians. Its product portfolio includes CAS-One IR for image-guided tumor ablation, the HEARO robotic system for cochlear implantation, and OTOPLAN software for patient-specific 3D inner ear reconstructions. The company serves healthcare professionals in oncology and otology to deliver reproducible and efficient minimally invasive treatments.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.